AbbVie Inc. (4AB.F)
Frankfurt - Frankfurt Delayed price. Currency in EUR
Add to watchlist
As of 04:40PM CEST. Market open.
| Previous close | 152.06 |
| Open | 152.02 |
| Bid | 153.16 x 60000 |
| Ask | 153.64 x 60000 |
| Day's range | 150.82 - 152.44 |
| 52-week range | 119.00 - 168.80 |
| Volume | |
| Avg. volume | 203 |
| Market cap | 269.189B |
| Beta (5Y monthly) | 0.58 |
| PE ratio (TTM) | 48.86 |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | 5.77 (3.64%) |
| Ex-dividend date | 15 Jul 2024 |
| 1y target est | N/A |
- Simply Wall St.
With 72% ownership, AbbVie Inc. (NYSE:ABBV) boasts of strong institutional backing
Key Insights Significantly high institutional ownership implies AbbVie's stock price is sensitive to their trading...
- Zacks
AbbVie (ABBV) Gets CHMP Nod for Lymphoma Drug's Expanded Use
AbbVie (ABBV) is seeking approval for Tepkinly in the EU as a monotherapy for the treatment of adult patients with relapsed/refractory follicular lymphoma after two or more prior therapies.
© 2024 Yahoo. All rights reserved.